471 – 480 of 2071
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Agents in early development for treatment of bladder dysfunction–promise of drugs acting at TRP channels?
(
- Contribution to journal › Article
-
Mark
What is understood by “animal-free research”?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
RIFM fragrance ingredient safety assessment, cyclopentanol, 2-(2-hexen-1-yl)-, CAS Registry Number 34686-67-4
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, coumarin, CAS Registry Number 91-64-5
(
- Contribution to journal › Article
-
Mark
The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model
(
- Contribution to journal › Article
-
Mark
Cangrelor for ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, 4-ethyloctanoic acid, CAS Registry Number 16493-80-4
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, ethyl benzoate, CAS Registry Number 93-89-0
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, m-dimethoxybenzene, CAS Registry Number 151-10-0
(
- Contribution to journal › Article